To test the validity and test-retest reliability of the Dutch translation of the Chronic Otitis Media Questionnaire 12 (COMQ-12).
INTRODUCTION
Chronic otitis media (COM) remains a common disease that has a serious health impact on up to 2% of the population [1] . In the assessment of healthcare, patient-based measuring instruments regarding the quality of life and perceived handicap have become increasingly important. Combining three COM-related quality of life questionnaires-the Chronic Ear Survey [1] , the Chronic Otitis Media Outcome Test 15 (COMOT-15) [2] , and the Chronic Otitis Media 5 (COM-5) [3] -the Chronic Otitis Media Questionnaire 12 (COMQ-12) is a disease-specific tool that was recently developed by Phillips et al. [4] to meet that purpose. The COMQ-12 consists of 12 questions grouped in four categories regarding the severity of symptoms, impact on lifestyle and work, impact on the health service, and general impact on the patient. Each question needs to be scored on a six-point ordinal scale from 0 (i.e., no impact) to 5 (i.e., most severe impact), depending on the level of inconvenience or frequency of symptoms. Initial validation has been completed, and this provides a useful clinical tool for the assessment of active COM [4] {Formatting Citation}. In 70 subjects without active chronic middle-ear disease, the overall mean score was 2, the modal score was 0 in 39% of participants, and the majority of participants had a total COMQ-12 score of 5 or less [5] .
The purpose of the present study was to culturally adapt the COMQ-12 to Flemish Dutch and to obtain measures of the validity and test-retest reliability of this Dutch translation of the original COMQ-12. The scores of controls were compared with those of patients to test the validity. The diagnostic accuracy or the ability of COMQ-12 to discriminate between normal subjects and subjects with chronic middle-ear pathology was investigated. Finally, the test-retest difference between two repeated administrations was assessed.
MATERIALS and METHODS
Firstly, the original COMQ-12 that was developed by Phillips et al. [4] was translated by the first three authors. The translation was sent to a native English-speaking person who has lived in Flanders for more than 40 years and speaks fluent Dutch. Secondly, this person translated the Dutch version back into English. Both the original and retranslated English versions of the COMQ-12 were then compared by the first three authors. There were no substantial differences between these two English versions; therefore, it was decided to adopt the Dutch version for further scientific and clinical use (Appendix A). As in the original COMQ-12, controls as well as patients were asked to rate the severity or frequency of their symptoms on a six-point equal-appearing interval scale from 0 (i.e., "this doesn't bother me at all or less frequently than once every 6 months") to 5 (i.e., "the worst thing that has ever affected my life or most days in the week").
Study Population
In total, 70 individuals were asked to complete a Dutch version of the COMQ-12. The control group consisted of 26 women with a mean age of 41.6 years [standard deviation (SD)=10.8; range=24-65] and nine men with a mean age of 40.9 years (SD=11.3; range=24-67) without a history of COM. These were healthy volunteers who were selected randomly from hospital staff (i.e., medical doctors, nurses, and administrative staff members) and among relatives and friends of the authors.
In addition to completing the COMQ-12, control subjects were also asked for their age and the presence of ear-related problems such as acute ear infections or previous ear surgery. One separate episode of infection was accepted; only a history that was consistent with COM led to exclusion. The dataset from the first completion (i.e., test) by the control subjects was called "control group 1. " The dataset from their second completion of the COMQ-12 questionnaire (i.e., retest) was referred to as "control group 2. "
The study group comprised 19 female subjects with a mean age of 36.2 years (SD=19.8; range=8-78) and 16 male subjects with a mean age of 41.7 years (SD=20.2; range=7-68) with COM. They visited our clinic in July 2015 with complaints of COM. The dataset from their completion of COMQ-12 was called "group 3. " All data were analyzed anonymously.
Statistics
Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS) Statistics version 20 (IBM; Armonk, NY, USA). For each analysis, a significance level of 5% was adopted. Various tests were used.
Firstly, the normality of the data distribution was investigated with the one-sample Kolmogorov-Smirnov test.
Secondly, the absolute scores of healthy participants and patients were analyzed with the non-parametric Mann-Whitney U-test to assess the validity of the questionnaire.
Thirdly, to examine the diagnostic value of COMQ-12, several estimates of diagnostic precision were calculated: sensitivity, specificity, and the area under a receiver operating characteristics curve (i.e., A ROC ). The A ROC statistic is interpreted as a score between 1.0 (for perfect discrimination between cases and non-cases) and 0.5 (for chance-level diagnostic accuracy). To facilitate the clinical interpretation of COMQ-12 scores, a threshold score for distinguishing normal from abnormal subjects was derived from the ROC curve.
Fourthly, to assess test-retest reliability, the single-measures type A intraclass correlation coefficient using an absolute agreement definition (i.e., ICC AA ) was calculated. Similar to other reliability coefficients, the ICC ranges from 0.00 (i.e., total absence of reliability) to 1.00 (i.e., perfect reliability). Although there are no standard criteria for the interpretation of ICC, a general guideline suggests that values of above 0.75 indicate good to excellent reliability, and values below 0.75 correspond to poor to moderate reliability [6] .
Ethics committee approval was received for this study from the ethics committee of the Sint-Augustinus Hospital, GZA Antwerp.
RESULTS

Study Population
In the control group of 35 healthy individuals, one participant reported a history of ear disease. This participant had undergone an ossiculoplasty for traumatic luxation of the incus. The overall COMQ-12 score in control group 1 ranged from 0 to 11, with a mean score of 1.43 (SD=2.30). In control group 2, the overall COMQ-12 scores ranged from 0 to 6, with a mean of 1.34 (SD=2.06). The COMQ-12 scores of the individual who reported an ear problem were 3 (test) and 6 (retest). The median COMQ-12 score overall was 0 in control groups 1 and 2, and the modal (or most prevalent) score was 0 in 18 participants (51.4%) in control group 1 and 21 participants (60%) in control group 2 (see Table  1 ). The distribution of control group 1 data was not normal (Kolmogorov-Smirnov Z=1.584; p=0.013). The distribution of control group 2 data was not normal (Kolmogorov-Smirnov Z=2.029; p=0.001).
The overall COMQ-12 scores in the patient group (group 3) ranged from 7 to 46, with a mean score of 27.80 (SD=10.51). The median overall COMQ-12 score was 28 ( Table 1) .
The distribution of group 3 data was normal (Kolmogorov-Smirnov Z=0.085; p=0.200). Non-parametric statistical methods were chosen based on the abnormal distribution of the data of the control subjects.
Validity
A comparison of the absolute COMQ-12 scores of the two control groups (control group 1 and group 2) with that of the patient group using the Mann-Whitney U-test showed that the COMQ-12 score was significantly higher in patients with COM than in control subjects (U=2.00; p=0.000).
To determine the diagnostic accuracy of COMQ-12 and its ability to distinguish normal from COM subjects, an ROC curve was constructed ( Figure 1) . The value of A ROC , with COMQ-12 scores as the test variable and the group (i.e., control group 1 versus group 3) as the state variable, was 0.998, which revealed very high discriminatory power to distinguish subjects with normal middle ears from those with chronically abnormal middle ears (with statistical significance at p<0.001). The ROC curve was also used to identify which cutoff point achieved the best balance between sensitivity and specificity and would provide optimal discrimination between experimental and control groups. In this regard, a COMQ-12 cutoff score of 8 produced estimates of sensitivity and specificity of 1.00 and 0.97, respectively. Therefore, using this threshold, 100% of patients were correctly classified as having COM, whereas 97% of non-cases were correctly categorized as normal.
Test-Retest Reliability
The single-measures ICC AA was 0.859 (with a 95% confidence interval from 0.738 to 0.926), which clearly exceeds the ICC threshold of 0.75 and confirmed that there was acceptable test-retest reliability with the control subjects.
DISCUSSION
The measurement of patient-based perception of the quality of life and handicaps has become very important in healthcare. The COMQ-12 is a patient-related outcomes questionnaire that is constructed to obtain information about the symptoms that are most important for the patient. It allows the clinician to get an idea of the expectations of patients regarding therapy and to choose an adequate management strategy that is consistent with these expectations [7] . We translated the original COMQ-12 into Dutch and tested it for validity, diagnostic accuracy, and test-retest reliability.
The scores for normal subjects, which varied from 0 to 11 and from 0 to 6 with mean scores of 1.43 and 1.34 as well as modal scores of 0 in 51.4% and 60% of the control participants for completion and recompletion, respectively, are comparable to the values for normal subjects calculated by Phillips et al. [5] A cutoff value of 8 was determined to distinguish between the absence and presence of COM, although in the control group one 44-year-old patient had a COMQ-12 score of 11 (test) and 6 (retest) in the absence of COM. This can be explained by a high score for the questions regarding hearing, which can be diminished in the absence of COM. Also, two patients reported COMQ-12 scores of 7 and 9. One had COM for years and had undergone several operations for this problem. Because the COMQ-12 is a patient-based measurement, the subjective inconvenience is assessed, and this patient was probably able to cope very well with his COM. The other patient had a small attical cholesteatoma in the absence of otorrhea and with good hearing, which was discovered because of a sensation of ear fullness and tinnitus.
The Dutch version of the COMQ-12 has good reproducibility and high diagnostic accuracy for detecting COM and can be used in clinical evaluation studies to assess the impact of surgery on patients' complaints.
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12. In welke mate halen uw oorproblemen u 'onderuit'? 0 1 2 3 4 5
Controleert u alstublieft dat u een antwoord heeft geformuleerd op elke vraag en vraag om hulp indien u dit moeilijk vindt.
Heel erg bedankt om deel te nemen.
APPENDIX A. Translated version of COMQ-12 (Continuous)
